These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Injectable neurotoxins and fillers: there is no free lunch. Emer J; Waldorf H Clin Dermatol; 2011; 29(6):678-90. PubMed ID: 22014990 [TBL] [Abstract][Full Text] [Related]
5. Injectable success: from fillers to Botox. Kelly PE Facial Plast Surg; 2007 Feb; 23(1):7-18; discussion 19-20. PubMed ID: 17330767 [TBL] [Abstract][Full Text] [Related]
6. Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations. Smith KC Dermatol Online J; 2008 Aug; 14(8):3. PubMed ID: 19061563 [TBL] [Abstract][Full Text] [Related]
7. Soft tissue augmentation 2006: filler fantasy. Klein AW Dermatol Ther; 2006; 19(3):129-33. PubMed ID: 16784511 [TBL] [Abstract][Full Text] [Related]
8. The evolution of soft tissue fillers in clinical practice. Murray CA; Zloty D; Warshawski L Dermatol Clin; 2005 Apr; 23(2):343-63. PubMed ID: 15837160 [TBL] [Abstract][Full Text] [Related]
9. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Christensen LH Dermatol Surg; 2009 Oct; 35 Suppl 2():1612-9. PubMed ID: 19807755 [TBL] [Abstract][Full Text] [Related]
10. ArteFill: a third-generation permanent dermal filler and tissue stimulator. Lemperle G; de Fazio S; Nicolau P Clin Plast Surg; 2006 Oct; 33(4):551-65. PubMed ID: 17085223 [TBL] [Abstract][Full Text] [Related]